Arcus Biosciences, Inc. Financial Ratios — RCUS Stock

Profitability (USD)

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	-35.43	-54.53	-59.77	-63.26
Return on Assets (%)	- -	-35.37	-21.31	-35.44	-25.22	4.48	-18.18	-25.16	-25.21	-30.84
Return on Capital (%)	- -	- -	- -	- -	- -	16.38	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	7.04	- -	- -	- -	- -
Gross Margin (%)	- -	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	- -	-3,597.24	-612.89	-567.54	-155.13	15.14	-244.64	-283.76	-116.28	-152.23
Operating Margin (%)	- -	-3,782.09	-656.76	-591.39	-158.97	14.1	-250	-290.6	-120.16	-156.28
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	58.36	- -	- -	- -	- -
Pretax Margin (%)	- -	-3,756.69	-593.73	-564.73	-157.69	14.36	-237.5	-257.26	-109.3	-142.91
Profit Margin (%)	- -	-3,756.69	-593.73	-564.73	-157.69	13.84	-238.39	-262.39	-109.69	-142.91
Net Income to Common Margin (%)	- -	-3,756.69	-593.73	-564.73	-157.69	13.84	-238.39	-262.39	-109.69	-142.91
Effective Tax Rate (%)	- -	- -	- -	- -	- -	3.64	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	-35.43	-54.53	-59.77	-63.26

Credit (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	15	117	3	11	60	112
ST Debt	- -	- -	- -	- -	- -	- -	3	11	12	13
LT Debt	- -	- -	- -	- -	15	117	- -	- -	48	99
Total Debt/EBITDA	- -	- -	- -	- -	-0.13	2.02	-0.01	-0.03	-0.2	-0.3
Net Debt/EBITDA	3.86	1.94	1.39	0.68	1.43	-2.55	0.75	0.38	0.34	0.33
Total Debt/EBIT	- -	- -	- -	- -	-0.12	2.16	-0.01	-0.03	-0.19	-0.29
Net Debt/EBIT	3.58	1.84	1.3	0.65	1.4	-2.74	0.74	0.37	0.33	0.32
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	-137	-166	-75	-47
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	-143	-178	-76.5	-47.25
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	-140	-170	-77.5	-48.25
Interest Expense	- -	- -	- -	- -	- -	- -	2	2	4	8
Common Equity/Total Assets	-18.37	-38.45	-44.68	-101.09	-42.49	52.95	49.37	42.19	42.17	55.4
Long-Term Debt/Equity (%)	- -	- -	- -	- -	3.03	13.88	- -	- -	9.9	15.69
Long-Term Debt/Capital (%)	- -	- -	- -	- -	-4.87	12.18	- -	- -	8.81	13.32
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	1.97	7.34	- -	- -	4.17	8.69
Total Debt/Equity (%)	- -	- -	- -	- -	3.03	13.88	0.46	2.38	12.37	17.75
Total Debt/Capital (%)	- -	- -	- -	- -	-4.87	12.18	0.45	2.33	11.01	15.07
Total Debt/Total Assets (%)	- -	- -	- -	- -	1.97	7.34	0.22	1	5.22	9.83
Net Debt to Equity	-65.51	-63.97	-30.25	-35.36	-34.52	-17.58	-31.35	-27.49	-21.03	-19.49
Net Debt/Capital (%)	-190.85	-180.48	36.65	22.01	35.66	-18.23	-44.69	-36.71	-25.82	-23.61
EBITDA	-17	-51	-51	-85	-121	58	-274	-332	-300	-376
EBITDA-CapEx	-21	-56	-55	-87	-124	32	-286	-356	-306	-378
Operating Income (Loss)	-18	-53	-55	-89	-124	54	-280	-340	-310	-386

Liquidity (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	17.83	13.81	15.15	8.29	5.99	3.01	5.23	4.12	4.33	4.25
Current Ratio	17.98	13.9	15.29	8.49	6.05	7.6	5.53	4.52	4.5	4.36
Quick Ratio	17.9	13.81	15.15	8.31	6	7.51	5.45	4.35	4.44	4.32
CFO/Avg Current Liab	- -	-2.74	-2.9	-3.71	1.54	-1.78	2.44	-1.62	-0.83	-2.11
Common Equity/Total Assets	-18.37	-38.45	-44.68	-101.09	-42.49	52.95	49.37	42.19	42.17	55.4
Long-Term Debt/Equity (%)	- -	- -	- -	- -	3.03	13.88	- -	- -	9.9	15.69
Long-Term Debt/Capital (%)	- -	- -	- -	- -	-4.87	12.18	- -	- -	8.81	13.32
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	1.97	7.34	- -	- -	4.17	8.69
Total Debt/Equity (%)	- -	- -	- -	- -	3.03	13.88	0.46	2.38	12.37	17.75
Total Debt/Capital (%)	- -	- -	- -	- -	-4.87	12.18	0.45	2.33	11.01	15.07
Total Debt/Total Assets (%)	- -	- -	- -	- -	1.97	7.34	0.22	1	5.22	9.83
CFO/Total Liabilities	-126.38	-68.43	-107.54	-187.08	41.11	-34.13	63.66	-48.34	-25.56	-94.88
CFO/CapEx	-3.16	-4.54	-11.49	-38.16	37	-9.85	36.5	-12.75	-28.33	-241
Altman's Z-Score	0.23	-0.42	5.4	4.99	3.09	3.18	0.91	0.05	-0.01	1.11

Working Capital (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	227.27	132.09	1.03	0.29	3.04	8.9	15.94
Days Sales Outstanding	- -	- -	- -	1.61	2.76	355.49	1,277.5	120.11	41.03	22.9
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	373	443	1,422	2,806	1,489	1,413	1,342	2,559
- Cash & Cash Equivalents	65	98	71	58	173	148	206	127	150	222
+ Preferred Equity and Hybrid Capital	119	226	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	15	117	3	11	60	112
Enterprise Value	21	50	116	254	709	2,424	483	665	424	1,690
Total Capital	99	153	-123	-205	-313	960	667	473	545	743
Total Debt/Capital (%)	- -	- -	- -	- -	-4.87	12.18	0.45	2.33	11.01	15.07
Total Debt / EV	- -	- -	- -	- -	0.02	0.05	0.01	0.02	0.14	0.07
EV/Sales	- -	35.73	13.92	16.96	9.09	6.33	4.31	5.69	1.64	6.84
EV/EBITDA	- -	- -	- -	- -	- -	41.8	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	44.89	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	6.39	- -	1.1	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	6.22	- -	1.07	- -	- -	- -
Diluted Market Cap	- -	- -	373	443	1,422	2,993	1,489	1,413	1,342	2,559
Diluted Enterprise Value	54	128	302	385	1,264	2,962	1,286	1,297	1,252	2,449
EV per Share	0.84	1.19	3.36	5.8	12.94	34.96	6.71	8.99	4.7	15.74
TTM Sales	- -	1	8	15	78	383	112	117	258	247
TTM EBITDA	-17	-51	-51	-85	-121	58	-274	-332	-300	-376
TTM Operating Income	-18	-53	-55	-89	-124	54	-280	-340	-310	-386
TTM Cash Flow to Firm	-13	-25	-43	-73	111	-256	440	-304	-166	-474
TTM Free Cash Flow to Firm	-9	-20	-39	-72	114	-230	452	-280	-160	-472

Multiples (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-9.5	-6.19	12.48	-13.01	3.31	-5.01	-8.18	-5.33
EV/EBIT	- -	- -	- -	- -	- -	44.89	- -	- -	- -	- -
Enterprise Value	21	50	116	254	709	2,424	483	665	424	1,690
Low Price	- -	- -	9.17	6.3	8.55	22.36	16.74	12.95	13.52	6.5
EV/Sales	- -	35.73	13.92	16.96	9.09	6.33	4.31	5.69	1.64	6.84
EV/EBITDA	- -	- -	- -	- -	- -	41.8	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	52.95	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-9.47	-4.81	-9.6	43.6	-7.54	-4.47	-5.21	-3.89
Price/Earnings High	- -	- -	-15.43	-7.07	-16.66	64.24	-11.34	-6.14	-6.47	-8.03
Price/Earnings Low	- -	- -	-6.4	-3.26	-3.81	29.26	-4.51	-3.12	-4.3	-1.98
Price/Book Value	- -	- -	-3.04	-2.16	-4.33	3.33	2.24	3.06	2.77	4.06
Price/Book Value Average	- -	- -	-3.82	-1.99	-3.6	2.74	3.03	2.97	3.04	2.18
Price/Book Value High	- -	- -	-6.23	-2.92	-6.25	4.04	4.56	4.08	3.77	4.49
Price/Book Value Low	- -	- -	-2.58	-1.34	-1.43	1.84	1.82	2.07	2.51	1.11
Price/Tangible Book Value	- -	- -	1.59	2.7	2.83	3.33	2.27	3.06	2.77	4.06
Price/Tangible Book Value Average	- -	- -	2	2.49	2.35	2.74	3.07	2.97	3.04	2.18
Price/Tangible Book Value High	- -	- -	3.26	3.65	4.08	4.04	4.61	4.08	3.77	4.49
Price/Tangible Book Value Low	- -	- -	1.35	1.69	0.93	1.84	1.83	2.07	2.51	1.11
Price/Sales	- -	- -	44.64	29.51	18.23	7.33	13.29	12.08	5.2	10.36
Price/Sales Average	- -	- -	56.21	27.19	15.13	6.03	17.98	11.73	5.72	5.56
Price/Sales High	- -	- -	91.59	39.91	26.28	8.89	27.03	16.11	7.09	11.48
Price/Sales Low	- -	- -	38	18.41	6.01	4.05	10.76	8.19	4.72	2.83
Price/Cash Flow	- -	- -	-8.67	-6.03	12.81	-10.96	3.4	-4.62	-7.89	-5.31
Price/Cash Flow Average	- -	- -	-10.92	-5.55	10.63	-9.03	4.6	-4.49	-8.68	-2.85
Price/Cash Flow High	- -	- -	-17.79	-8.15	18.46	-13.3	6.91	-6.16	-10.76	-5.88
Price/Cash Flow Low	- -	- -	-7.38	-3.76	4.22	-6.06	2.75	-3.13	-7.17	-1.45
Price/Free Cash Flow Average	- -	- -	-11.96	-5.7	10.35	-10.72	4.48	-4.87	-8.99	-2.86
Price/Free Cash Flow High	- -	- -	-19.49	-8.37	17.98	-15.79	6.73	-6.68	-11.16	-5.91
Price/Free Cash Flow Low	- -	- -	-8.09	-3.86	4.11	-7.19	2.68	-3.4	-7.43	-1.45
EV/Sales Average	- -	90.42	47.71	23.33	13.1	5.95	16.17	10.74	5.37	5.11
EV/Sales High	- -	90.42	83.08	36.05	24.25	8.81	25.22	15.12	6.74	11.03
EV/Sales Low	- -	90.42	29.5	14.54	3.98	3.97	8.95	7.2	4.37	2.38
EV/EBITDA Average	-3.22	-2.51	-7.78	-4.11	-8.45	39.3	-6.61	-3.79	-4.62	-3.36
EV/EBITDA High	-3.22	-2.51	-13.56	-6.35	-15.63	58.17	-10.31	-5.33	-5.8	-7.25
EV/EBITDA Low	-3.22	-2.51	-4.81	-2.56	-2.56	26.2	-3.66	-2.54	-3.76	-1.56
EV/EBIT Average	-2.99	-2.39	-7.26	-3.94	-8.24	42.21	-6.47	-3.7	-4.47	-3.27
EV/EBIT High	-2.99	-2.39	-12.65	-6.1	-15.25	62.48	-10.09	-5.2	-5.61	-7.06
EV/EBIT Low	-2.99	-2.39	-4.49	-2.46	-2.5	28.14	-3.58	-2.48	-3.64	-1.52
Last Price	- -	- -	10.77	10.1	25.96	40.47	20.68	19.1	14.89	23.83
High Price	- -	- -	22.1	13.66	37.41	49.1	42.05	25.47	20.31	26.4
Enterprise Value Average	54	128	398	350	1,022	2,279	1,811	1,257	1,385	1,263
Enterprise Value High	54	128	694	541	1,891	3,374	2,825	1,769	1,740	2,725
Enterprise Value Low	54	128	246	218	310	1,519	1,002	842	1,128	588

Shares Outstanding	43	43	45	46	65	71	73	76	92	125
Diluted Weighted Avg Shares	25	43	35	44	55	74	72	74	90	107
Basic Weighted Avg Shares	25	43	35	44	55	69	72	74	90	107
Revenue per Share	- -	0.03	0.24	0.34	1.42	5.52	1.56	1.58	2.86	2.3
EBITDA per Share	-0.69	-1.19	-1.48	-1.94	-2.21	0.84	-3.81	-4.49	-3.33	-3.5
Operating Income per Share	-0.74	-1.26	-1.58	-2.02	-2.26	0.78	-3.89	-4.59	-3.44	-3.59
Basic EPS, GAAP	-0.73	-1.25	-1.43	-1.93	-2.25	0.76	-3.71	-4.15	-3.14	-3.29
Basic EPS from Cont Ops	-0.73	-1.25	-1.43	-1.93	-2.25	0.76	-3.71	-4.15	-3.14	-3.29
Diluted EPS, GAAP	-0.73	-1.25	-1.43	-1.93	-2.25	0.72	-3.71	-4.15	-3.14	-3.29
Diluted EPS from Cont Ops	-0.73	-1.25	-1.43	-1.93	-2.25	0.72	-3.71	-4.15	-3.14	-3.29
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.53	-0.59	-1.24	-1.68	2.03	-3.69	6.08	-4.14	-1.89	-4.49
Free Cash Flow per Basic Share	-0.69	-0.72	-1.35	-1.72	1.97	-4.07	5.92	-4.46	-1.95	-4.51
Cash & Equivalents per Share	4.03	4.13	7.41	4.3	13.3	7.2	14.01	10.26	10.85	9.13
Book Value per Share	-0.82	-1.72	-3.55	-4.68	-5.99	12.16	9.22	6.24	5.38	5.88
Tangible Book Value per Share	-0.81	-1.7	6.79	3.74	9.17	12.14	9.12	6.24	5.38	5.88

Arcus Biosciences, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)